Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...
Proteintech has designed recombinant antibodies featuring the company's FcZero backbone, engineered to silence the Fc domain ...
Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...
Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...